Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Leite

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Journal of Neuroimmunology|May 2, 2021
High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, MalaysiaChee Keong Wong, Jyh Yung Hor, Yin Pin Loo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2017
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodiesBethan Lang, Mateusz Makuch, Teresa Moloney, et al.
Neurology|December 14, 2020
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic ReviewViktoria Papp, Melinda Magyari, Orhan Aktas, et al.
Brain : a Journal of Neurology|May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanJoanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Annals of Clinical and Translational Neurology|February 2, 2024
Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitisSophie N M Binks, Michele Veldsman, Adam E Handel, et al.
JAMA Neurology|September 10, 2014
Opportunistic infections of the retina in patients with aquaporin-4 antibody diseaseJithin S George, Maria Isabel Leite, Joanna L Kitley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Brain : a Journal of Neurology|November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK studyMaciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Journal of Neuroimmunology|May 2, 2021
High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, MalaysiaChee Keong Wong, Jyh Yung Hor, Yin Pin Loo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 29, 2021
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disordersValentina Camera, Silvia Messina, Kariem Tarek Elhadd, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2017
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodiesBethan Lang, Mateusz Makuch, Teresa Moloney, et al.
Neurology|December 14, 2020
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic ReviewViktoria Papp, Melinda Magyari, Orhan Aktas, et al.
Brain : a Journal of Neurology|May 12, 2012
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and JapanJoanna Kitley, M Isabel Leite, Ichiro Nakashima, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Annals of Clinical and Translational Neurology|February 2, 2024
Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitisSophie N M Binks, Michele Veldsman, Adam E Handel, et al.
JAMA Neurology|September 10, 2014
Opportunistic infections of the retina in patients with aquaporin-4 antibody diseaseJithin S George, Maria Isabel Leite, Joanna L Kitley, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Brain : a Journal of Neurology|November 15, 2017
Clinical presentation and prognosis in MOG-antibody disease: a UK studyMaciej Jurynczyk, Silvia Messina, Mark R Woodhall, et al.
Pageof 19